Scholarlink

<p>Oncogenic codon V600E mutations of the <i>BRAF</i> gene affect 10–15% of colorectal cancers, resulting in activation of the MAPK/ERK signaling pathway and increased cell proliferation and survival. <i>BRAF-</i>mutated colorectal tumors are often microsatellite unstable and characterized by high DNA methylation levels. However, the mechanistic link between <i>BRAF</i> mutations and hypermethylation remains controversial. Understanding this link, particularly in microsatellite stable tumors is of great interest as these often show poor survival. We characterized the metabolomic, epigenetic and transcriptomic patterns of altogether 39 microsatellite stable <i>BRAF-</i>mutated colorectal cancers. Metabolomic analysis of tumor tissue showed low levels of vitamin C and its metabolites in <i>BRAF-</i>mutated tumors. Gene expression analysis indicated dysregulation of vitamin C antioxidant activity in these lesions. As vitamin C is an important cofactor for the activity of TET DNA demethylase enzymes, low vitamin C levels could directly contribute to the high methylation levels in these tumors by decreasing enzymatic TET activity. Vitamin C transporter gene <i>SLC23A1</i> expression, as well as vitamin C metabolite levels, were inversely correlated with DNA methylation levels. This work proposes a new mechanistic link between <i>BRAF</i> mutations and hypermethylation, inspiring further work on the role of vitamin C in the genesis of <i>BRAF-</i>mutated colorectal cancer.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comprehensive metabolomic and epigenomic characterization of microsatellite stable BRAF-mutated colorectal cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月18日

查看全文
  • Aurora Taira,
  • Mervi Aavikko,
  • Riku Katainen,
  • Eevi Kaasinen,
  • Niko Välimäki,
  • Janne Ravantti,
  • Ari Ristimäki,
  • Toni T. Seppälä,
  • Laura Renkonen-Sinisalo,
  • Anna Lepistö,
  • Kyösti Tahkola,
  • Anne Mattila,
  • Selja Koskensalo,
  • Jukka-Pekka Mecklin,
  • Jan Böhm,
  • Jesper Bertram Bramsen,
  • Claus Lindbjerg Andersen,
  • Kimmo Palin,
  • Kristiina Rajamäki,
  • Lauri A. Aaltonen

摘要

Oncogenic codon V600E mutations of the BRAF gene affect 10–15% of colorectal cancers, resulting in activation of the MAPK/ERK signaling pathway and increased cell proliferation and survival. BRAF-mutated colorectal tumors are often microsatellite unstable and characterized by high DNA methylation levels. However, the mechanistic link between BRAF mutations and hypermethylation remains controversial. Understanding this link, particularly in microsatellite stable tumors is of great interest as these often show poor survival. We characterized the metabolomic, epigenetic and transcriptomic patterns of altogether 39 microsatellite stable BRAF-mutated colorectal cancers. Metabolomic analysis of tumor tissue showed low levels of vitamin C and its metabolites in BRAF-mutated tumors. Gene expression analysis indicated dysregulation of vitamin C antioxidant activity in these lesions. As vitamin C is an important cofactor for the activity of TET DNA demethylase enzymes, low vitamin C levels could directly contribute to the high methylation levels in these tumors by decreasing enzymatic TET activity. Vitamin C transporter gene SLC23A1 expression, as well as vitamin C metabolite levels, were inversely correlated with DNA methylation levels. This work proposes a new mechanistic link between BRAF mutations and hypermethylation, inspiring further work on the role of vitamin C in the genesis of BRAF-mutated colorectal cancer.